FDA grants IND clearance to Zabalafin Hydrogel, a botanical drug targeting bacterial, inflammatory, and pruritic components of atopic dermatitis, following successful Phase 2a trials.
An outbreak of measles in Gaines County, Texas, has led to at least 24 reported cases, with none of the infected individuals being vaccinated, sparking concerns of potential further spread in the community.
The FDA has approved Evolysse Form and Smooth, the latest hyaluronic acid fillers. Their approval "represent[s] the first major technological breakthrough in hyaluronic acid dermal fillers in a decade," noted the manufacturer.
With no new FDA-approved drugs for chronic wound debridement since 1965, MediWound's phase 3 trial tests EscharEx for venous leg ulcers in 216 patients.
“Each subsequent infection could potentially increase the burden on the immune system, leaving individuals vulnerable to the cumulative effects of the virus."
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
“You are instilling fear into folks who may defer care, who may go without care, whose children may not get the vaccines they need, who may not be able to get treatment for an ear infection or surgery."
2023 brought record-breaking heat waves in the United States, significantly impacting vulnerable groups. Analysis by the CDC revealed a substantial number of heat-related illness (HRI) emergency department visits, resulting in multiple public health alerts.